Full roll-out of general practice-based pharmacotherapy service delayed until 2022–2023 A pharmacotherapy service, which was expected to be running in every GP practice in Scotland from April 2021, has been delayed.…
Pharmaceutical considerations for patients with stomas Pharmacists should be aware of the requirements of their patients who may have a temporary or permanent stoma.…
Pharmacotherapy service will not be standard across Scotland The design of the GP-based pharmacotherapy service planned for Scotland; including whether it is provided mainly by pharmacists or technicians, is being left to local decisions, it has emerged.…
Refractory epilepsy: management in tertiary care Epilepsy is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness or convulsions, associated with neurones exhibiting abnormally high electrical excitability in the brain.…
One-stop resource for pharmacists in HIV care HIV pharmacotherapy: the pharmacist’s role in care and treatment, edited by Jason J Schafer, Jennifer M Cocohoba, Elizabeth M Sherman and Alice L Tseng.…
Scottish pharmacotherapy service set to go ahead A pharmacotherapy service is to be developed in Scotland after the country’s first GP contract was strongly backed by family doctors.…
New pharmacotherapy service to be set up as part of Scottish GP contract A new pharmacotherapy service could be developed in Scotland as part of a proposed new GP contract.…
Study upholds use of metformin monotherapy for first-line diabetes treatment Patients recently diagnosed with diabetes who are prescribed metformin monotherapy are less likely to require treatment intensification compared with patients prescribed other oral glucose-lowering medications as a monotherapy.…
Treatment of schizophrenia should not be limited to drugs, says WHOTreatment of schizophrenia should not be limited to pharmacotherapy but should also include psychosocial interventions, says the World Health Organization (WHO).…
